ANTIKÖRPERFORMULIERUNG

European patent · EP3593814 · In force

Register entry

Publication number
EP3593814
Application number
EP19185836
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 11, 2013
Published
Jan 15, 2020
Granted
Jan 21, 2026
Protection ends at the latest
Jun 10, 2033
Next annual fee due
Jun 30, 2027
IPC classes
A61K 39/395 (2006.01)
A61K 9/00 (2006.01)
A61K 47/18 (2017.01)
A61K 47/26 (2006.01)
C07K 16/28 (2006.01)
A61P 29/00 (2006.01)
A61P 35/02 (2006.01)
Priority
US 201261658472 P 12.06.2012
Divided from
EP13744818
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jan 21, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.01.2026

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

Cosenza, Marta

4002 Basel

Stark, Christoph

4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.